US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Bee venom which is also known as apitoxin is produced by female worker bees and is known to contain many active components peptides like melittin, apamin, mast cell degranulating (MCD) peptide, and adolapin. Various enzymes, such as phospholipase A2 (PLA2) and hyaluronidase along with amino acids and volatile compounds. Several studies are ongoing for the therapeutic potential of these components in treating human inflammatory diseases as well as central nervous system diseases, such as Parkinsons disease (PD), Alzheimers disease (AD), and amyotrophic lateral sclerosis (ALS), Bee venom extract has also shown beneficial anti-cancer and anti-viral potential against ovarian and prostate cancer, breast cancer as well as HIV. Bee venom extracts are usually delivered in a freeze-dried form (lyophilization) to assure a long shelf life and there is an advantage that targeted dilutions are easy to achieve. There is ongoing research on the therapeutic applications of Bee Venom as an Anti-Inflammatory, treatment of neurodegenerative diseases like Parkinsons Disease(PD), Alzheimers Disease(AD), and Amyotrophic Lateral Sclerosis(ALS). The use of apitoxin, especially its main compound melittin, as a novel cancer-treatment strategy has gained wide importance. In fact, melittin is known to be a nonspecific cytolytic peptide that can attack the lipid bilayer, thus leading to significant toxicity when injected intravenously. Nevertheless, many optimization approaches, including the use of nanoparticle-based delivery of melittin, have been exploited. Remarkably, the crude BV as well as melittin have shown antitumor activities against different cancer cell types including breast, liver, leukemia, lung, melanoma, and prostate cancer cells. In September 2020, Harry Perkins Institue of Medical Research(Australia) was published in a prestigious international journal NJP Nature Precision Oncology. The research showed honeybee venom rapidly destroyed triple-negative breast cancer and HER2-enriched breast cancer cells. Triple-negative breast cancer, until now has limited treatment options. Cancer institute records indicate Triple-negative breast cancer accounts for 10 to 15 percent of all breast cancer. As per the research, a very small, positively charged peptide in honeybee venom called melittin significantly, selectively, and rapidly reduced the viability of triple-negative breast cancer and HER2-enriched breast cancer cells. Melittin within 20 minutes, was able to substantially reduce the chemical messages of cancer cells that are essential to cancer cell growth and cell division and completely destroy cancer cell membranes within 60 minutes. Melittin could also be used with small molecules or chemotherapies, such as docetaxel, to treat highly-aggressive types of breast cancer. The combination of melittin and docetaxel was extremely efficient in reducing tumour growth in mice. More about the research here. Bee venom plays an effective role in the improvement of skin wrinkles, and it is used in the cosmetics industry as an antiwrinkle agent. Bee-venom serum provided greater efficacy in terms of total wrinkle area, total wrinkle counts, and average wrinkle depth along with photodamaged skin. Long-term treatment with bee venom-containing cosmetics is considered to be safe because the irritation potential of bee venom is negligible. Bee venom is being increasingly used in products for common acne (everyday pimple) and cystic acne as both conditions can cause inflammation and puffiness. Numerous cosmetic products like face creams, body butter, face masks, moisturizing lotions, and anti-wrinkle products now contain varying amounts of Bee Venom. The global Bee Venom Extract market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. In terms of production side, this report researches the Bee Venom Extract production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type. In terms of consumption side, this report focuses on the consumption of Bee Venom Extract by regions (countries) and by Application. The global Bee Venom Extract market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Bee Venom Extract market. These figures have been provided in terms of both revenue and volume for the period 2015-2026. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic SegmentationThe report offers an exhaustive assessment of different region-wise Bee Venom Extract markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E For the period 2015-2025, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Bee Venom Extract market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
ManufacturersThe report includes comprehensive company profiling of leading and emerging companies competing in the global Bee Venom Extract market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Bee Venom Extract market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2015-2020.
By Type and Application SegmentsThe report includes a detailed analysis of leading and type and application segments of the global Bee Venom Extract market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Bee Venom Extract market by each type segment for the period 2015-2025. It also offers volume sales (consumption) analysis and forecast of the global Bee Venom Extract market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Bee Venom Extract market by each application segment for the same period.
This report includes the following manufacturers:
- ApiHealth NZ
- Citeq Biologics
- Chung-Jin Biotech
- New Technology Laboratory Ltd (USA)
- Hangzhou Golden Harvest Health Industry
- Bee Venom Labs LLC
Market Segment by Type
- Liquid Type
- Powder Type
Market Segment by Application
- Cosmetic & Personal Care
Research MethodologyTo compile the detailed study of the global Bee Venom Extract market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Bee Venom Extract market. Trusted Business Insights analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Bee Venom Extract market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
Table of Contents Chapter 1. Preface 1.1. Report Description 1.1.1. Objective 1.1.2. Target Audience 1.1.3. Unique Selling Proposition (USP) & Offerings 1.2. Research Scope 1.3. Research Methodology 1.3.1. Market Research Process 1.3.2. Market Research Methodology 1.3.3. Level 1: Primary Research 1.3.4. Level 2: Secondary Research 1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope Chapter 2. Executive Summary 2.1. Global Bee Venom Extract 2019-2029 (USD Billion) 2.2. Global Bee Venom Extract: Market Snapshot Chapter 3. Global Bee Venom Extract - Industry Analysis | read more...